PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.45
+5.02%Next report
Analyst consensus
- Next report date
- Dec 16, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 14, 2026
- EPS actual
- -$0.54
- EPS estimate
- -$0.06
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -254.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 14, 2026 | -$0.06 | -$0.54 | Miss -800.00% | — |
| Mar 17, 2026 | — | -$0.17 | — | — |
| Dec 18, 2025 | — | -$0.32 | — | — |
| Sep 15, 2025 | — | -$0.09 | — | — |
| Mar 17, 2025 | — | -$0.10 | — | — |
| Dec 13, 2024 | — | -$0.29 | — | — |
| Sep 16, 2024 | — | $0.14 | — | — |
| Mar 18, 2024 | — | -$0.65 | — | — |
| Dec 15, 2023 | — | -$0.64 | — | — |
| Sep 18, 2023 | — | -$0.28 | — | — |
| Mar 16, 2023 | -$0.08 | -$0.04 | Beat 50.00% | — |
| Dec 14, 2022 | -$0.08 | -$0.09 | Miss -12.50% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 16, 2026